Collegium Expands ADHD Support with New Resource Hub

  • Collegium Pharmaceutical launched 'Start Talking ADHD', an online resource hub for ADHD patients and caregivers.
  • The hub includes three downloadable guides for healthcare, school, and everyday support conversations.
  • Collegium added a second ADHD medication to its portfolio in May 2026.
  • The company became an Official Partner of Boston Legacy Football Club in February 2026.

Collegium Pharmaceutical is expanding its commitment to ADHD support beyond medication, aligning with broader industry trends towards holistic patient care. The launch of 'Start Talking ADHD' and the addition of a second ADHD medication to its portfolio indicate a strategic shift towards comprehensive ADHD management. The company's partnership with Boston Legacy Football Club further underscores its focus on community engagement and patient support.

Market Positioning
Whether Collegium can leverage its expanded ADHD portfolio to strengthen its market position.
Patient Engagement
The impact of the 'Start Talking ADHD' hub on patient and caregiver engagement with healthcare providers.
Community Initiatives
The effectiveness of Collegium's community initiatives, such as the partnership with Boston Legacy Football Club, in enhancing brand visibility and patient support.